MoneyWorks4Me

Cohance Lifesciences informs about investor conference

20 Feb 2026 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cohance Lifesciences has informed that the management of the Company will be attending IIFL Entrepreneurial India Conference on February 25, 2026 and Kotak Chasing Growth Conference on February 26, 2026 in Mumbai (Group/One-one). No unpublished price-sensitive information will be shared during this interaction.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..